Now showing items 1-4 of 4
Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial.
(Oxford University Press., 2014)
The Centre for the AIDS Programme of Research in South Africa 004 (CAPRISA 004) study demonstrated that vaginally applied tenofovir gel is a promising intervention for protecting women from sexually acquiring human ...
Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial.
Abstract not available in pdf.
The preventive misconception: experiences from CAPRISA 004.
Abstract available in pdf.
Limited HIV-1 superinfection in seroconverters from the CAPRISA 004 Microbicide trial.
(American Society for Microbiology., 2014)
HIV-1 superinfection (SI) occurs when an infected individual acquires a distinct new viral strain. The rate of superinfection may be reflective of the underlying HIV risk in a population. The Centre for the AIDS Programme ...